NEW YORK (GenomeWeb) – University of Washington spinout TwinStrand Biosciences has raised around $2 million in seed funding and opened a next-generation sequencing laboratory in Seattle. The startup plans to commercialize technology known as duplex sequencing for applications such as oncology and forensics.
TwinStrand Biosciences currently has seven full-time employees, including CEO Michael Kranda, and is looking to at least double in size by the end of year, co-founder Jesse Salk said in an interview.